Dynavax Technologies
DVAX
#5505
Rank
ยฃ0.96 B
Marketcap
ยฃ8.18
Share price
-0.46%
Change (1 day)
-19.42%
Change (1 year)

Dynavax Technologies (DVAX) - Net assets

Net assets on the balance sheet as of September 2025 : ยฃ0.40 Billion

According to Dynavax Technologies 's latest financial reports the company has ยฃ0.40 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Dynavax Technologies - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ0.47 B-2.6%
2023-12-31$ยฃ0.48 B1.67%
2022-12-31$ยฃ0.48 B191.52%
2021-12-31$ยฃ0.16 B282.59%
2020-12-31$ยฃ43.05 M581.11%
2019-12-31$ยฃ6.32 M-87.28%
2018-12-31$ยฃ49.68 M-66.35%
2017-12-31$ยฃ0.14 B104.24%
2016-12-31$ยฃ72.29 M-42.74%
2015-12-31$ยฃ0.12 B95.6%
2014-12-31$ยฃ64.53 M-42.85%
2013-12-31$ยฃ0.11 B58.97%
2012-12-31$ยฃ71.04 M10.55%
2011-12-31$ยฃ64.26 M90.36%
2010-12-31$ยฃ33.75 M756.74%
2009-12-31$ยฃ3.94 M-64.26%
2008-12-31$ยฃ11.02 M-44.04%
2007-12-31$ยฃ19.69 M-51.21%
2006-12-31$ยฃ40.36 M-6.39%
2005-12-31$ยฃ43.12 M38.26%
2004-12-31$ยฃ31.18 M-197.54%
2003-12-31$-ยฃ31.98 Million-9.05%
2002-12-31$-ยฃ35.16 Million48.11%
2001-12-31$-ยฃ23.74 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agenus
AGEN
-ยฃ0.22 Billion-152.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ13.64 B 3,308.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ38.90 B 9,617.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ16.08 B 3,916.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ34.45 B 8,506.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
ยฃ15.87 B 3,864.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ69.78 B 17,329.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ5.43 B 1,258.08%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
ยฃ7.21 B 1,700.85%๐Ÿ‡บ๐Ÿ‡ธ USA